Tuesday - March 17, 2026
Blood Test Predicts Which Bladder Cancer Patients May Safely Skip Surgery
February 26, 2026
PHILADELPHIA, Pennsylvania, Feb. 26 [Category: Health Care] -- The Fox Chase Cancer Center, a part of Temple University Health System, posted the following news:

* * *

Blood Test Predicts Which Bladder Cancer Patients May Safely Skip Surgery

*

* The ctDNA blood test predicts metastatic risk, but not local recurrence, after bladder-sparing cancer treatment.

* Researchers said ctDNA could be used to help select patients likely to . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products